Double Medical Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Equivalents	1,222	1,076	1,228	992.67	410.19
Short-Term Investments	-	-	-	-	41.3
Trading Asset Securities	496.97	172.75	433.2	358.67	769.71
Cash & Short-Term Investments	1,719	1,249	1,661	1,351	1,221
Cash Growth	37.67%	-24.83%	22.92%	10.66%	11.29%
Accounts Receivable	302.87	235.67	242.52	324.97	457.99
Other Receivables	13.3	9.87	10.46	8.75	9.79
Receivables	316.17	245.54	252.97	333.72	467.77
Inventory	1,235	1,273	1,193	987.35	670.15
Other Current Assets	69.23	44.6	48.06	53.79	35.97
Total Current Assets	3,339	2,812	3,155	2,726	2,395
Property, Plant & Equipment	1,194	1,193	1,071	877.68	698.72
Long-Term Investments	-	-	-	-	1.33
Goodwill	61.86	67.77	68.27	69.13	69.68
Other Intangible Assets	116.93	125.61	136.92	143.16	148.59
Long-Term Deferred Tax Assets	11.38	14.43	8.93	7.04	8.26
Long-Term Deferred Charges	196.64	203.1	197.49	109.61	57.27
Other Long-Term Assets	4.19	2.95	1.93	4.69	0.9
Total Assets	4,924	4,419	4,640	3,938	3,380
Accounts Payable	266.64	253.32	281.64	345.36	296.3
Accrued Expenses	134.66	157	128.41	107.16	131.39
Short-Term Debt	-	80.75	316.84	0.59	2.41
Current Portion of Long-Term Debt	12.36	50.63	2.88	1.4	-
Current Portion of Leases	-	6.01	8.27	6.32	5.04
Current Income Taxes Payable	63.89	20.59	4.93	11.5	45.58
Current Unearned Revenue	132.03	118.95	171.94	136.96	58.48
Other Current Liabilities	268.6	254.15	238.81	107.31	182.59
Total Current Liabilities	878.18	941.4	1,154	716.6	721.78
Long-Term Debt	296.03	243.67	261.32	47.96	-
Long-Term Leases	5.01	4.63	10.88	12.9	13.61
Long-Term Unearned Revenue	55.84	45.51	50.13	48.68	48.51
Long-Term Deferred Tax Liabilities	1.13	2.11	3.08	5.01	7.57
Other Long-Term Liabilities	2.8	-	-	-	-
Total Liabilities	1,239	1,237	1,479	831.15	791.47
Common Stock	414.02	414.02	414.02	414.02	405.14
Additional Paid-In Capital	1,130	1,104	1,102	1,102	594.23
Retained Earnings	2,197	1,800	1,547	1,488	1,605
Treasury Stock	-166.61	-234.98	-	-	-89.79
Comprehensive Income & Other	-4.16	-4.31	-4.25	-4.05	-1.66
Total Common Equity	3,570	3,079	3,058	3,000	2,512
Minority Interest	115.24	102.62	102.16	106.65	75.91
Shareholders' Equity	3,685	3,182	3,161	3,106	2,588
Total Liabilities & Equity	4,924	4,419	4,640	3,938	3,380
Total Debt	313.4	385.68	600.2	69.17	21.06
Net Cash (Debt)	1,406	863.01	1,061	1,282	1,200
Net Cash Growth	62.88%	-18.65%	-17.26%	6.83%	9.37%
Net Cash Per Share	3.45	2.08	2.52	3.05	2.98
Filing Date Shares Outstanding	411.87	406.61	414.02	414.02	401.23
Total Common Shares Outstanding	411.87	406.61	414.02	414.02	401.23
Working Capital	2,461	1,870	2,002	2,010	1,673
Book Value Per Share	8.67	7.57	7.39	7.25	6.26
Tangible Book Value	3,391	2,886	2,853	2,787	2,294
Tangible Book Value Per Share	8.23	7.10	6.89	6.73	5.72
Buildings	-	730.83	409.91	324.68	315.79
Machinery	-	865.43	805.97	736.92	552.66
Construction In Progress	-	80.24	238.25	113.1	51.56

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.